» Articles » PMID: 22976034

Predicting the Biological Activities Through QSAR Analysis and Docking-based Scoring

Overview
Specialty Molecular Biology
Date 2012 Sep 15
PMID 22976034
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Numerous computational methodologies have been developed to facilitate the process of drug discovery. Broadly, they can be classified into ligand-based approaches, which are solely based on the calculation of the molecular properties of compounds, and structure-based approaches, which are based on the study of the interactions between compounds and their target proteins. This chapter deals with two major categories of ligand-based and structure-based methods for the prediction of biological activities of chemical compounds, namely quantitative structure-activity relationship (QSAR) analysis and docking-based scoring. QSAR methods are endowed with robustness and good ranking ability when applied to the prediction of the activity of closely related analogs; however, their great dependence on training sets significantly limits their applicability to the evaluation of diverse compounds. Instead, docking-based scoring, although not very effective in ranking active compounds on the basis of their affinities or potencies, offer the great advantage of not depending on training sets and have proven to be suitable tools for the distinction of active from inactive compounds, thus providing feasible platforms for virtual screening campaigns. Here, we describe the basic principles underlying the prediction of biological activities on the basis of QSAR and docking-based scoring, as well as a method to combine two or more individual predictions into a consensus model. Finally, we describe an example that illustrates the applicability of QSAR and molecular docking to G protein-coupled receptor (GPCR) projects.

Citing Articles

Molecular Mechanism of Indoor Exposure to Airborne Halogenated Flame Retardants TCIPP (Tris(1,3-Dichloro-2-Propyl) Phosphate) and TCEP Tris(2-chloroethyl) Phosphate and Their Hazardous Effects on Biological Systems.

Alharbi A, Alhujaily M Metabolites. 2024; 14(12).

PMID: 39728479 PMC: 11677016. DOI: 10.3390/metabo14120697.


Harnessing Drug Repurposing to Combat Breast Cancer by Targeting Altered Metabolism and Epithelial-to-Mesenchymal Transition Pathways.

Kandasamy T, Sarkar S, Ghosh S ACS Pharmacol Transl Sci. 2024; 7(12):3780-3794.

PMID: 39698277 PMC: 11650739. DOI: 10.1021/acsptsci.4c00545.


AI and ML-based risk assessment of chemicals: predicting carcinogenic risk from chemical-induced genomic instability.

Singh A, Bhardwaj P, Laux P, Pradeep P, Busse M, Luch A Front Toxicol. 2024; 6:1461587.

PMID: 39659701 PMC: 11628524. DOI: 10.3389/ftox.2024.1461587.


A Chronicle Review of Approaches for Discovering Novel Antimicrobial Agents to Combat Antimicrobial Resistance.

Dalbanjan N, Praveen Kumar S Indian J Microbiol. 2024; 64(3):879-893.

PMID: 39282180 PMC: 11399514. DOI: 10.1007/s12088-024-01355-x.


Searching for Protein Off-Targets of Prostate-Specific Membrane Antigen-Targeting Radioligands in the Salivary Glands.

Julian W, Sergeeva O, Cao W, Wu C, Erokwu B, Flask C Cancer Biother Radiopharm. 2024; 39(10):721-732.

PMID: 39268679 PMC: 11824224. DOI: 10.1089/cbr.2024.0066.


References
1.
Cavasotto C, Orry A, Murgolo N, Czarniecki M, Kocsi S, Hawes B . Discovery of novel chemotypes to a G-protein-coupled receptor through ligand-steered homology modeling and structure-based virtual screening. J Med Chem. 2008; 51(3):581-8. DOI: 10.1021/jm070759m. View

2.
Bhattacharya S, Subramanian G, Hall S, Lin J, Laoui A, Vaidehi N . Allosteric antagonist binding sites in class B GPCRs: corticotropin receptor 1. J Comput Aided Mol Des. 2010; 24(8):659-74. DOI: 10.1007/s10822-010-9364-2. View

3.
Carlsson J, Yoo L, Gao Z, Irwin J, Shoichet B, Jacobson K . Structure-based discovery of A2A adenosine receptor ligands. J Med Chem. 2010; 53(9):3748-55. PMC: 2865168. DOI: 10.1021/jm100240h. View

4.
Cramer R, Patterson D, Bunce J . Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. J Am Chem Soc. 2011; 110(18):5959-67. DOI: 10.1021/ja00226a005. View

5.
Vilar S, Karpiak J, Costanzi S . Ligand and structure-based models for the prediction of ligand-receptor affinities and virtual screenings: Development and application to the beta(2)-adrenergic receptor. J Comput Chem. 2009; 31(4):707-20. PMC: 2818076. DOI: 10.1002/jcc.21346. View